Corporate Member Update- Amgen

Corporate Member Update- Amgen

LUMAKRAS® (sotorasib)
May, 2025

We’re excited to share that LUMAKRAS® (sotorasib) in combination with Vectibix® (panitumumab) is approved in a new indication. Please see the product website and the full Prescribing Information for LUMAKRAS® and Vectibix® for more information including the BOXED WARNING and Important Safety Information.

 
 
Become a NOS Member Today!
Join Now
 

Platinum Corporate Members

Gold Corporate Members